 table S1 (Microsoft Excel format). Transcriptome data of ADR-treated HCT116 cells.  table S2 (Microsoft Excel format). Proteome data of ADR-treated HCT116 cells.
fig. S1. Schematics of the integrated multi-OMICS approach. The screen criteria in transcriptome and proteome analysis are shown. p53 target candidates in each time point are highlighted in the red box. Arrow: peaks derived from ASS1.
fig. S2. Examination of genotoxic stress-induced ASS1 mRNA expression. For ADR treatment, cells were treated with 2 g/ml ADR for 2 hr, then cultured with fresh medium. For X-ray irradiation, cells were irradiated with X-ray at a dose of either 5 Gy or 20 Gy. For Nutlin-3a treatment (Nut3a), cells were cultured with 10 M Nutlin-3a. For arginine starvation (ARG(-)), cells were cultured with arginine-free medium. 48 hr after the treatment, the expression level of ASS1 mRNA (A) and p21/CDKN1A mRNA (B) in cells were determined by qPCR analysis. level of ASS1 protein in HCT116 p53 +/+ cells and HCT116 p53 -/cells were examined by western blotting analysis. For ADR, cells were treated with 2 g/ml ADR for 2 hr and then given fresh medium. For X-ray irradiation, cells were irradiated with 20 Gy of X-ray. At 48 hr after treatment, cells were subjected to western blot analysis. (B) ASS1-deficient HCT116 cells were generated by CRISPR-Cas9 genome editing system. Two different gRNAs were used to establish monoclonal cell lines sgASS1-1 and sgASS1-2, respectively. The AAVS1 locus was targeted as a negative control. These cells were treated with 0.5 g/ml (left) or 2 g/ml (right)
